Literature DB >> 7092803

Characterization of two new electrophoretic variants of human triosephosphate isomerase: stability, kinetic, and immunological properties.

J Asakawa, H W Mohrenweiser.   

Abstract

Two new electrophoretic variants of human triosephosphate isomerase (TPI) have been partially purified and characterized. The TPI Manchester variant, a cathodally migrating electrophoretic allozyme identified in an individual with the phenotype TPI 1-Manchester, is associated with a normal level of enzyme activity in erythrocytes and normal kinetic properties. It is very thermolabile at 55 and 57 degrees C, although it is not uniquely sensitive to either guanidine-HCl or urea denaturation. The TPI Hiroshima-2 variant is an anodally migrating allozyme (the phenotype of proband is TPI 1-Hiroshima-2) with normal activity and kinetic properties and also normal stability characteristics. It is inactivated less by antisera raised against normal human TPI than either the normal or the Manchester allozyme. Dissociation-reassociation experiments utilizing these allozymes have confirmed that normal human red blood cell TPI isozymes are produced by a sequence of reactions (presumably deamidations) involving alternating subunits.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092803     DOI: 10.1007/BF00484936

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  32 in total

1.  Triosephosphate isomerase from human erythrocytes.

Authors:  R W Gracy
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  HEREDITARY HEMOLYTIC ANEMIA WITH TRIOSEPHOSPHATE ISOMERASE DEFICIENCY.

Authors:  A S SCHNEIDER; W N VALENTINE; M HATTORI; H L HEINS
Journal:  N Engl J Med       Date:  1965-02-04       Impact factor: 91.245

3.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

4.  Removal of triosephosphate isomerase from albumins.

Authors:  D W Porter; B G Harris; R W Gracy
Journal:  Prep Biochem       Date:  1973

5.  Studies on human triosephosphate isomerase. II. Nature of the electrophoretic multiplicity in erythrocytes.

Authors:  T H Sawyer; B E Tilley; R W Gracy
Journal:  J Biol Chem       Date:  1972-10-25       Impact factor: 5.157

6.  Methods for starch-gel electrophoresis of sarcoplasmic proteins. An investigation of the relative mobilities of the glycolytic enzymes from the muscles of a variety of species.

Authors:  R K Scopes
Journal:  Biochem J       Date:  1968-03       Impact factor: 3.857

7.  A new isozyme of triose phosphate isomerase specific to hominoids.

Authors:  H Rubinson; M C Meienhofer; J C Dreyfus
Journal:  J Mol Evol       Date:  1973-11-27       Impact factor: 2.395

8.  Useful buffer and gel systems for polyacrylamide gel electrophoresis.

Authors:  H R Maurer; R C Allen
Journal:  Z Klin Chem Klin Biochem       Date:  1972-05

9.  Origin of the triosephosphate isomerase isozymes in humans: genetic evidence for the expression of a single structural locus.

Authors:  R S Decker; H W Mohrenweiser
Journal:  Am J Hum Genet       Date:  1981-09       Impact factor: 11.025

10.  The isolation and characterization of the multiple forms of human skeletal muscle triosephosphate isomerase.

Authors:  S W Eber; W K Krietsch
Journal:  Biochim Biophys Acta       Date:  1980-07-10
View more
  57 in total

Review 1.  Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases.

Authors:  Rita M Meganck; Ralph S Baric
Journal:  Nat Med       Date:  2021-03-15       Impact factor: 53.440

2.  Cell proliferation-associated expression of a recently evolved isozyme of triosephosphate isomerase.

Authors:  R S Decker; H W Mohrenweiser
Journal:  Biochem Genet       Date:  1985-04       Impact factor: 1.890

3.  Human triosephosphate isomerase: substitution of Arg for Gly at position 122 in a thermolabile electromorph variant, TPI-Manchester.

Authors:  B A Perry; H W Mohrenweiser
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

4.  Origin of human triosephosphate isomerase isozymes: further evidence for the single structural locus hypothesis with Japanese variants.

Authors:  J Asakawa; S Iida
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Electrophoretic variants of blood proteins in Japanese. III. Triosephosphate isomerase.

Authors:  J Asakawa; C Satoh; N Takahashi; M Fujita; J Kaneko; K Goriki; R Hazama; T Kageoka
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  Curcumin and Piperine in COVID-19: A Promising Duo to the Rescue?

Authors:  Mahsa Miryan; Davood Soleimani; Gholamreza Askari; Tannaz Jamialahmadi; Paul C Guest; Mohammad Bagherniya; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review.

Authors:  Sarvin Radvar; Sepideh Karkon-Shayan; Ali Motamed-Sanaye; Mohammadreza Majidi; Sakineh Hajebrahimi; Negar Taleschian-Tabrizi; Fariba Pashazadeh; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Characterization of three electrophoretic variants of human erythrocyte triosephosphate isomerase found in Japanese.

Authors:  J Asakawa; C Satoh
Journal:  Biochem Genet       Date:  1986-02       Impact factor: 1.890

9.  Single-cell landscape of immunological responses in patients with COVID-19.

Authors:  Ji-Yuan Zhang; Xiang-Ming Wang; Xudong Xing; Zhe Xu; Chao Zhang; Jin-Wen Song; Xing Fan; Peng Xia; Jun-Liang Fu; Si-Yu Wang; Ruo-Nan Xu; Xiao-Peng Dai; Lei Shi; Lei Huang; Tian-Jun Jiang; Ming Shi; Yuxia Zhang; Alimuddin Zumla; Markus Maeurer; Fan Bai; Fu-Sheng Wang
Journal:  Nat Immunol       Date:  2020-08-12       Impact factor: 25.606

10.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.